Elekta ABMEX:EKTAB N 79 FCF Margin % is 23.96% as of Apr. 2026, which is 270% above its 10-year median of 6.48. GuruFocus rates MEX:EKTAB N with a GF Score™ of 79/100 and a GF Value™ of MXN158.57. The stock has 6 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Elekta AB ranks better than 69.33% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Elekta AB's Free Cash Flow for the
three
months ended in Apr. 2026 was MXN2,156 Mil. Elekta AB's Revenue for the
three
months ended in Apr. 2026 was MXN8,999 Mil. Therefore, Elekta AB's FCF Margin % for the quarter that ended in Apr. 2026 was 23.96%.
The historical rank and industry rank for Elekta AB's FCF Margin % or its related term are showing as below:
MEX:EKTAB N'
s FCF Margin % Range Over the Past 10 Years
Min: 1.73 Med: 6.48 Max: 13.39
Current: 8.18
During the past 13 years, the highest FCF Margin % of Elekta AB was 13.39%. The lowest was 1.73%. And the median was 6.48%.
MEX:EKTAB N's FCF Margin % is ranked better than 69.33% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs MEX:EKTAB N: 8.18
Elekta AB FCF Margin % Related Terms
Elekta AB FCF Margin % Historical Data
* Premium members only.
The historical data trend for Elekta AB's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:EKTAB N vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Elekta AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elekta AB FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Elekta AB's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elekta AB (MEX:EKTAB N) has a FCF Margin % of 23.96% as of Apr. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Elekta AB and its competitors. This is 270% above median its historical median of 6.48. Over the past decade, Elekta AB's FCF Margin % has ranged from 1.73 to 13.39. According to the industry distribution chart, Elekta AB ranks #250 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 30.7%.
Is Elekta AB's FCF Margin % too high?
Elekta AB's current FCF Margin % of 23.96% is 270% above median its 10-year median of 6.48. Over the past 10 years, this metric has ranged from a low of 1.73 to a high of 13.39. Based on the distribution chart, Elekta AB ranks #250 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Elekta AB has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Elekta AB ranks #250 out of 815 companies for FCF Margin %. This puts Elekta AB in the upper half of its industry. Historically, Elekta AB's own FCF Margin % has ranged from 1.73 to 13.39 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Elekta AB and its competitors. Elekta AB's current FCF Margin % is 23.96%, which is 270% above median its own 10-year median of 6.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Elekta AB (MEX:EKTAB N) has a current FCF Margin % of 23.96%. The stock's GF Value™ is MXN158.57, compared to a current price of MXN126.63 — trading 20.1% below its estimated fair value. The current FCF Margin % is 23.96%, which is 270% above median its 10-year median of 6.48. Elekta AB's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Elekta AB (MEX:EKTAB N), the current FCF Margin % is 23.96% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elekta AB (MEX:EKTAB N) Overvalued in 2026?
Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued.
The current stock price of MXN126.63 is trading 20.1% below its estimated GF Value™ of MXN158.57.
Key valuation signals for MEX:EKTAB N:
FCF Margin %: 23.96% (270% above median its 10-year median of 6.48)
GF Value™: MXN158.57 vs. price of MXN126.63 (20.1% below fair value)
No single metric tells the full story. See the MEX:EKTAB N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
79GF Score
Get the complete analysis for MEX:EKTAB N
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:EKTAB N has been successfully added to your 
